Difference between revisions of "CT Volumetry Biomarker Ctte"

From QIBA Wiki
Jump to: navigation, search
Line 50: Line 50:
 
==Reference Materials==
 
==Reference Materials==
  
===2012===
+
'''2012'''
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
*Dr Mulshine's Presentation Materials from July 2nd adapted from the ATCC Website
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
**[[Media:ATCC is an independent private nonprofit 7-3-12.pdf|ATCC is an independent, private, nonprofit biological resource center (BRC) and research organization.]]
 
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
 
*[[Media:Why_QIBA_CT_specifics.pdf|"Why QIBA?" - Specifics associated with CT device and software manufacturers.]]
  
===2011===
+
'''2011'''
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*Dr Petrick's 2011 SPIE Presentation Materials
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
 
*[[Media:Spie2011 NP QIBA1A-Talk-v05-final-1.pdf|“Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging” - Talk]]
Line 61: Line 61:
 
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
 
*Compliance Documents: [[Media:Approach to Compliance 2011 08 15.pdf|QIBA Approach to Compliance-- ''Andrew J. Buckler, MS, Program Director, QIBA 08.15.11'']]
  
===2010===
+
'''2010'''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media:Quantification in Imaging-Dr Dirk Colditz-20100823.ppt|Quantification in Imaging-Dr Dirk Colditz]] ''August 23, 2010''
 
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
 
*[[Media: Plan as of 11-8-10.jpg|Project plan]] ''.jpg version as of 11-8-10''
Line 73: Line 73:
 
*[[Archive - Initial Target Selection and Roadmap]]
 
*[[Archive - Initial Target Selection and Roadmap]]
  
==Round 1 of QIBA Funded Projects==
+
==QIBA Funded Projects==
  
 +
'''Round 1'''
 
*[[Duke University]]
 
*[[Duke University]]
 
*[[Columbia University Medical Center]]
 
*[[Columbia University Medical Center]]
Line 81: Line 82:
 
*[[CoreLab Partners, Inc.]]
 
*[[CoreLab Partners, Inc.]]
  
==Round 2 of QIBA Funded Projects==
+
'''Round 2'''
 
+
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[CoreLab Partners, Inc., Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]
 
*[[David Geffen School of Medicine at UCLA, Department of Radiology,Round-2]]

Revision as of 17:56, 7 August 2017

Co-chairs: Gregory Goldmacher, MD, PhD, MBA; Jenifer Siegelman, MD, MPH; Ehsan Samei, PhD
Secretary: Julie Lisiecki
Roster

Meetings

  • Tcons are held roughly Weekly. Contact the secretary for details.
  • Call Summaries

Profile Development

Advanced Disease/Tumor Volume Change Profile

Status - Consensus Profile complete

Status - Technical Confirmation in progress

  • Columbia Volume repeatability assessment - Coming Soon

Past and Future


Lung Nodule Assessment in CT Screening Profile

Status - Public Comment complete

Status - Consensus in progress

Past

Groundwork Projects

These projects investigate (and resolve) scientific questions underlying QIBA Profile work.

  • VolCT - Group 1A - Analyze Bias/Variance where Ground Truth is Known Deterministically
  • VolCT - Group 1B - Focus on Volume Change Analysis of Pulmonary Nodules in Diagnostic Settings
  • VolCT - Group 1C - Model Sources of Variability from a Systems Engineering Analysis
  • VolCT - Group 3A - Characterize variability due to algorithms (using phantoms / clinical data)
  • VolCT - Group 3B - Characterize clinical utility/efficacy with respect to clinical endpoints
  • VolCT - Colorado Group - Quantifying variability in measurement of pulmonary nodule

Reference Materials

2012

2011

2010

Reference Articles

  • Are we ready? A time for measurement of physiological parameters of the lung using multidetector row CT scans. Hatabu H. Acad Radiol. 2009 Mar; 16(3):249. Academic Radiology
  • Radiology 2007 - Coronary Calcium Scoring - This paper by Dr. McCollough et al is may be seen to be analaogous to our work in that it addresses similar issues (e.g. achieving "standard" noise levels). It could be thought of as an early draft of a Calcium Scoring profile, including both groundwork and equipment specifications.
  • Helical multidetector row quantitative computed tomography (QCT) precision. Bligh M, Bidaut L, White RA, Murphy WA Jr, Stevens DM, Cody DD. Acad Radiol. 2009 Feb; 16(2):150-9. Academic Radiology
  • Comparison of the accuracy of CT volume calculated by circumscription to prolate ellipsoid volume (bidimensional measurement multiplied by coronal long axis). Rkein AM, Harrigal C, Friedman AC, Persky D, Krupinski E. Acad Radiol. 2009 Feb; 16(2):181-6. Academic Radiology

QIBA Funded Projects

Round 1

Round 2